{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T21:05:09Z","timestamp":1778965509066,"version":"3.51.4"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI125207"],"award-info":[{"award-number":["T32 AI125207"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NCI75903"],"award-info":[{"award-number":["NCI75903"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U54CA221204"],"award-info":[{"award-number":["U54CA221204"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["D43TW010354"],"award-info":[{"award-number":["D43TW010354"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Although the immune response is likely to play a pivotal role in controlling Kaposi sarcoma (KS)-associated herpesvirus (KSHV) and preventing disease development, the exact factors responsible for that control remain ill defined. T cell responses are weak and variable, and neutralizing Abs are more frequently detected in individuals with KS. This suggests a potential role for nonneutralizing Abs, which to date have been largely uninvestigated. Ab-dependent cell cytotoxicity (ADCC) is a common effector function for nonneutralizing Abs and is known to play a protective role in other herpesvirus infections; yet, ADCC has never been investigated in the context of KSHV infection. In this study, we provide, to our knowledge, the first evidence that anti-KSHV Abs are capable of mediating ADCC responses against infected human cells undergoing lytic reactivation. ADCC activity significantly higher than seronegative controls was detected in 24 of 68 KSHV-seropositive individuals tested. However, ADCC responses were not associated with KS development or progression. ADCC activity was also found to be independent of HIV status, sex, age, KSHV Ab titer, and KSHV-neutralizing activity. Nevertheless, additional investigations into effector cell function between KS and asymptomatic individuals are needed to determine whether ADCC has a role in preventing KS.<\/jats:p>","DOI":"10.4049\/jimmunol.2000489","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:30:19Z","timestamp":1601501419000},"page":"2742-2749","source":"Crossref","is-referenced-by-count":10,"title":["The Presence of Antibody-Dependent Cell Cytotoxicity\u2013Mediating Antibodies in Kaposi Sarcoma\u2013Associated Herpesvirus\u2013Seropositive Individuals Does Not Correlate with Disease Pathogenesis or Progression"],"prefix":"10.1093","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9506-372X","authenticated-orcid":false,"given":"Lisa K","family":"Poppe","sequence":"first","affiliation":[{"name":"Nebraska Center for Virology , Lincoln, NE 68583"},{"name":"School of Biological Sciences, University of Nebraska-Lincoln , Lincoln, NE 68583"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Wood","sequence":"additional","affiliation":[{"name":"Nebraska Center for Virology , Lincoln, NE 68583"},{"name":"School of Biological Sciences, University of Nebraska-Lincoln , Lincoln, NE 68583"},{"name":"Department of Biochemistry, University of Nebraska-Lincoln , Lincoln, NE 68583"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4594-6855","authenticated-orcid":false,"given":"John T","family":"West","sequence":"additional","affiliation":[{"name":"Nebraska Center for Virology , Lincoln, NE 68583"},{"name":"Department of Biochemistry, University of Nebraska-Lincoln , Lincoln, NE 68583"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,15]]},"reference":[{"key":"2025030417505698400_r1","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"2025030417505698400_r2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM199505043321801","article-title":"Detection of herpesvirus-like DNA sequences in Kaposi\u2019s sarcoma in patients with and those without HIV infection","volume":"332","author":"Moore","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2025030417505698400_r3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2025030417505698400_r4","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"2025030417505698400_r5","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.22236","article-title":"Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma","volume":"107","author":"Brown","year":"2006","journal-title":"Cancer"},{"key":"2025030417505698400_r6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi sarcoma","volume":"5","author":"Cesarman","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2025030417505698400_r7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.1969.03150210077009","article-title":"Disseminated visceral Kaposi\u2019s sarcoma. Appearance after human renal homograft operation","volume":"207","author":"Siegel","year":"1969","journal-title":"JAMA"},{"key":"2025030417505698400_r8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1089\/aid.2016.0155","article-title":"Regulatory T cell effect on CD8+ T cell responses to human herpesvirus 8 infection and development of Kaposi\u2019s sarcoma","volume":"33","author":"Lepone","year":"2017","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"2025030417505698400_r9","doi-asserted-by":"crossref","first-page":"109402","DOI":"10.18632\/oncotarget.22683","article-title":"T-cell responses to KSHV infection: a systematic approach","volume":"8","author":"Roshan","year":"2017","journal-title":"Oncotarget"},{"key":"2025030417505698400_r10","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/ijc.29329","article-title":"Trends in Kaposi\u2019s sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi\u2019s sarcoma: a nested case-control study","volume":"136","author":"Wakeham","year":"2015","journal-title":"Int. J. Cancer"},{"key":"2025030417505698400_r11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071254","article-title":"Higher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"key":"2025030417505698400_r12","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/eji.201040661","article-title":"Killing of Kaposi\u2019s sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells","volume":"41","author":"Matthews","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"2025030417505698400_r13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002486","article-title":"Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma","volume":"8","author":"Dupuy","year":"2012","journal-title":"PLoS Pathog."},{"key":"2025030417505698400_r14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1196\/annals.1397.068","article-title":"Control of human herpes virus type 8-associated diseases by NK cells","volume":"1096","author":"Sirianni","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025030417505698400_r15","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/1521-4141(2002010)32:10<2711::AID-IMMU2711>3.0.CO;2-3","article-title":"NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi\u2019s sarcoma","volume":"32","author":"Sirianni","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"2025030417505698400_r16","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.3390\/v6114358","article-title":"Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysis","volume":"6","author":"G\u00f6rander","year":"2014","journal-title":"Viruses"},{"key":"2025030417505698400_r17","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.4049\/jimmunol.1500872","article-title":"NK cell and Ig interplay in defense against herpes simplex virus type 1: epistatic interaction of CD16A and IgG1 allotypes of variable affinities modulates antibody-dependent cellular cytotoxicity and susceptibility to clinical reactivation","volume":"195","author":"Moraru","year":"2015","journal-title":"J. Immunol."},{"key":"2025030417505698400_r18","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3389\/fimmu.2019.02110","article-title":"The roles of host and viral antibody Fc receptors in herpes simplex virus (HSV) and human cytomegalovirus (HCMV) infections and immunity","volume":"10","author":"Jenks","year":"2019","journal-title":"Front. Immunol."},{"key":"2025030417505698400_r19","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. [Published erratum appears in 2015 Cell Rep. 12: 901.]","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell Rep."},{"key":"2025030417505698400_r20","first-page":"1","article-title":"Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis","volume":"25","author":"Jondal","year":"1976","journal-title":"Clin. Exp. Immunol."},{"key":"2025030417505698400_r21","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1128\/JVI.01019-12","article-title":"Construction and manipulation of a new Kaposi\u2019s sarcoma-associated herpesvirus bacterial artificial chromosome clone","volume":"86","author":"Brulois","year":"2012","journal-title":"J. Virol."},{"key":"2025030417505698400_r22","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/infdis\/jiy654","article-title":"Similar immunological profiles between African endemic and human immunodeficiency virus type 1-associated epidemic Kaposi sarcoma (KS) patients reveal the primary role of KS-associated herpesvirus in KS pathogenesis","volume":"219","author":"Lidenge","year":"2019","journal-title":"J. Infect. Dis."},{"key":"2025030417505698400_r23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/ijc.27729","article-title":"Early childhood infection of Kaposi\u2019s sarcoma-associated herpesvirus in Zambian households: a molecular analysis","volume":"132","author":"Olp","year":"2013","journal-title":"Int. J. Cancer"},{"key":"2025030417505698400_r24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/aje\/kwq465","article-title":"The Zambia children\u2019s KS-HHV8 study: rationale, study design, and study methods","volume":"173","author":"Minhas","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"2025030417505698400_r25","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/jmv.24546","article-title":"Longitudinal analysis of the humoral response to Kaposi\u2019s sarcoma-associated herpesvirus after primary infection in children","volume":"88","author":"Olp","year":"2016","journal-title":"J. Med. Virol."},{"key":"2025030417505698400_r26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/CDLI.8.6.1131-1135.2001","article-title":"Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants","volume":"8","author":"Neri","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"2025030417505698400_r27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141074","article-title":"A novel method for assessment of natural killer cell cytotoxicity using image cytometry","volume":"10","author":"Somanchi","year":"2015","journal-title":"PLoS One"},{"key":"2025030417505698400_r28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1158\/1055-9965.EPI-13-0730","article-title":"Risk factors for early childhood infection of human herpesvirus-8 in Zambian children: the role of early childhood feeding practices","volume":"23","author":"Crabtree","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2025030417505698400_r29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4049\/jimmunol.1601574","article-title":"Antibody-dependent NK cell activation differentially targets EBV-infected cells in lytic cycle and bystander B lymphocytes bound to viral antigen-containing particles","volume":"199","author":"L\u00f3pez-Monta\u00f1\u00e9s","year":"2017","journal-title":"J. Immunol."},{"key":"2025030417505698400_r30","doi-asserted-by":"crossref","first-page":"9738","DOI":"10.1128\/JVI.77.18.9738-9749.2003","article-title":"Productive lytic replication of a recombinant Kaposi\u2019s sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells","volume":"77","author":"Gao","year":"2003","journal-title":"J. Virol."},{"key":"2025030417505698400_r31","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417505698400_r32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/251350a0","article-title":"Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus","volume":"251","author":"Shore","year":"1974","journal-title":"Nature"},{"key":"2025030417505698400_r33","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/infdis\/170.6.1439","article-title":"Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets","volume":"170","author":"Khyatti","year":"1994","journal-title":"J. Infect. Dis."},{"key":"2025030417505698400_r34","first-page":"11","article-title":"Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt\u2019s lymphoma in relation to tumour development","volume":"29","author":"Jondal","year":"1977","journal-title":"Clin. Exp. Immunol."},{"key":"2025030417505698400_r35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/clinids\/13.1.108","article-title":"Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections","volume":"13","author":"Kohl","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"2025030417505698400_r36","doi-asserted-by":"crossref","first-page":"72961","DOI":"10.18632\/oncotarget.12150","article-title":"PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma","volume":"7","author":"Beldi-Ferchiou","year":"2016","journal-title":"Oncotarget"},{"key":"2025030417505698400_r37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JVI.01777-06","article-title":"The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing","volume":"81","author":"Pappworth","year":"2007","journal-title":"J. Virol."},{"key":"2025030417505698400_r38","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1128\/JVI.78.7.3601-3620.2004","article-title":"Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi\u2019s sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression","volume":"78","author":"Krishnan","year":"2004","journal-title":"J. Virol."},{"key":"2025030417505698400_r39","volume-title":"Fields Virology.","author":"Knipe","year":"2013"},{"key":"2025030417505698400_r40","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.96.8.4546","article-title":"Distribution of human herpesvirus-8 latently infected cells in Kaposi\u2019s sarcoma, multicentric Castleman\u2019s disease, and primary effusion lymphoma","volume":"96","author":"Dupin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417505698400_r41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi\u2019s sarcoma and its associated herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"2025030417505698400_r42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/jvi.71.1.715-719.1997","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells","volume":"71","author":"Staskus","year":"1997","journal-title":"J. Virol."},{"key":"2025030417505698400_r43","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa288","article-title":"Relationships between maternal antibody responses and early childhood infection with Kaposi sarcoma\u2013associated herpesvirus","author":"Poppe","year":"2020","journal-title":"J. Infect. Dis."},{"key":"2025030417505698400_r44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004046","article-title":"Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome","volume":"10","author":"Labo","year":"2014","journal-title":"PLoS Pathog."},{"key":"2025030417505698400_r45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jviromet.2011.03.012","article-title":"Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction","volume":"174","author":"Myoung","year":"2011","journal-title":"J. Virol. Methods"},{"key":"2025030417505698400_r46","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/ijc.27849","article-title":"Kaposi\u2019s sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line","volume":"132","author":"St\u00fcrzl","year":"2013","journal-title":"Int. J. Cancer"},{"key":"2025030417505698400_r47","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1158\/0008-5472.CAN-12-1851","article-title":"mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis","volume":"73","author":"Roy","year":"2013","journal-title":"Cancer Res."},{"key":"2025030417505698400_r48","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02183-18","article-title":"Reduction of Kaposi\u2019s sarcoma-associated herpesvirus latency using CRISPR-Cas9 to edit the latency-associated nuclear antigen gene","volume":"93","author":"Tso","year":"2019","journal-title":"J. Virol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/205\/10\/2742\/61879339\/ji2000489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/205\/10\/2742\/61879339\/ji2000489.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:12:36Z","timestamp":1741111956000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/205\/10\/2742\/7931026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,11,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.2000489","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,11]]}}}